Studies have shown that CAFs enhance the migration (through CCL2 and CCL5 secretion) and invasion (through CCL7 and CXCL16) of HCC cells in vitro and could promote HCC metastasis to distant sites, including the bone. The gene discussed is CCL2; the disease is hepatocellular carcinoma.